@article{daedab0458c74522b7245bcf4577e298,
title = "Chronic myelogenous leukemia",
keywords = "BCR-ABL, Chronic myelogenous leukemia, Dasatinib, Imatinib, NCCN clinical practice guidelines, NCCN guidelines, Nilotinib, Stem cell transplant, Tyrosine kinase inhibitor",
author = "Susan O'Brien and Abboud, \{Camille N.\} and Mojtaba Akhtari and Jessica Altman and Ellin Berman and DeAngelo, \{Daniel J.\} and Steven Devine and Fathi, \{Amir T.\} and Jason Gotlib and Madan Jagasia and Moore, \{Joseph O.\} and Javier Pinilla-Ibarz and Radich, \{Jerald P.\} and Reddy, \{Vishnu V.B.\} and Shah, \{Neil P.\} and Shami, \{Paul J.\} and Smith, \{B. Douglas\} and Snyder, \{David S.\} and Meir Wetzler and Furhan Yunus",
year = "2012",
month = jan,
day = "1",
doi = "10.6004/jnccn.2012.0009",
language = "English (US)",
volume = "10",
pages = "64--110",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Harborside Press",
number = "1",
}